The Oncology Institute, Inc. announced the signing of an expanded partnership agreement with McKesson Corporation for drug distribution and clinical technology. The multi-year agreement is intended to streamline TOI's pharmaceutical distribution logistics and provide operational and financial alignment to continue, and execute upon, the Company's expansion strategy.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | -1.67% | -4.07% | -42.16% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.16% | 87.69M | |
-14.92% | 84.87B | |
+13.30% | 83.08B | |
+10.92% | 29.4B | |
-12.71% | 16.72B | |
-3.06% | 16.4B | |
-2.63% | 15.04B | |
-3.97% | 11.88B | |
-1.42% | 11.88B | |
-31.75% | 11.86B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- The Oncology Institute Announces Expanded Strategic Agreement with McKesson for Distribution of Pharmaceuticals